Literature DB >> 2645075

Bone quality. Roentgenographic versus histologic assessment of hip bone structure.

B N Stulberg1, T W Bauer, J T Watson, B Richmond.   

Abstract

Bone quality is an accepted criterion for determining fixation options for total hip arthroplasty (THA). Eighty patients with 95 uncemented THAs were evaluated by comparing preoperative roentgenographic assessment with histologic evaluation of bone biopsy specimens obtained from the ipsilateral iliac crest. Roentgenographic analysis of bone quality was performed using the Singh and Engh indices. Histologic evaluation employed a quantitative analysis of static and dynamic parameters of bone turnover on undecalcified sections. Extensive statistical analysis comparing roentgenographic with histologic parameters of bone quality showed: (1) no relationship of the two roentgenographic indices to trabecular bone volume and most other histologic parameters and (2) a high incidence of bone abnormalities. Bone quality is an imprecise term and is inadequately measured by these roentgenographic indices. Histologic measurement offers a more precise means of analyzing the relationship of the bone environment to the performance of the THA.

Entities:  

Mesh:

Year:  1989        PMID: 2645075

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Dual X-ray absorptiometry for the evaluation of bone density from the proximal femur after total hip arthroplasty: analysis protocols and reproducibility.

Authors:  C Trevisan; M Bigoni; R Cherubini; P Steiger; G Randelli; S Ortolani
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

2.  Classification of acetabular changes in osteoarthritis: a histological and radiological analysis of 122 consecutive drill biopsies routinely taken during THA.

Authors:  Martin Clauss; Thomas Ilchmann; Peter Zimmermann; Matthias U Schafroth; Martin Lüem; Peter E Ochsner
Journal:  Surg Radiol Anat       Date:  2008-05-27       Impact factor: 1.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.